S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

TNFA TNF Pharmaceuticals Inc

0.3803

0.0013 (0.34%)

Last Updated: 00:30:04

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

TNF Pharmaceuticals (NASDAQ:TNFA)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more TNF Pharmaceuticals Charts.

TNF Pharmaceuticals (NASDAQ:TNFA)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more TNF Pharmaceuticals Charts.

TNF Pharmaceuticals Inc News

Form 8-K - Current report
Tuesday 11 March 2025 (2 days ago) • Edgar (US Regulatory)

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor
Wednesday 26 February 2025 (2 weeks ago) • Business Wire

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment
Thursday 30 January 2025 (1 month ago) • Business Wire

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion
Thursday 16 January 2025 (2 months ago) • Business Wire

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs
Friday 20 December 2024 (3 months ago) • Business Wire

Premarket Action Is Heating Up For This Biotech
Wednesday 11 December 2024 (3 months ago) • AllPennyStocks.com

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference
Tuesday 10 December 2024 (3 months ago) • Business Wire

Form 8-K - Current report
Wednesday 27 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (4 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (4 months ago) • Edgar (US Regulatory)

Form ARS - Annual Report to Security Holders
Saturday 2 November 2024 (4 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Saturday 2 November 2024 (4 months ago) • Edgar (US Regulatory)

More TNF Pharmaceuticals Inc News Articles

State Street Global Advi...

INTESA SANPAOLO

BNP Paribas Issuance

Societe Generale Effekten

Amundi Physical Gold

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions